TABLE 1.
Tumor cell | Normoxia group | SF | 95% CI | Hypoxia group | SF | 95% CI |
Tca8113 | X4 | 0.45 | 0.30–0.60 | X4 | 0.97 | 0.80–1.14 |
Tca8113 | P4 | 0.46 | 0.25–0.67 | P4 | 0.76 | 0.50–1.02 |
Tca8113 | C4 | 0.42 | 0.32–0.52 | C4 | 0.58 | 0.49–0.66 |
Cal27 | X4 | 0.62 | 0.23–1.00 | X4 | 0.91 | 0.83–1.01 |
Cal27 | P4 | 0.76 | 0.50–1.04 | P4 | 1.02 | 0.90–1.15 |
Cal27 | C4 | 0.06 | 0.04–0.09 | C4 | 0.25 | 0.16–0.35 |
Ln229 | X4 | 0.80 | 0.66–0.90 | X4 | 0.97 | 0.79–1.16 |
Ln229 | P4 | 0.48 | 0.07–0.89 | P4 | 0.76 | 0.45–1.08 |
Ln229 | C4 | 0.43 | 0.28–0.58 | C4 | 0.53 | 0.31–0.75 |
Ln18 | X4 | 0.60 | 0.22–0.99 | X4 | 0.93 | 0.80–1.05 |
Ln18 | P4 | 0.27 | 0.10–0.44 | P4 | 0.84 | 0.77–0.91 |
Ln18 | C4 | 0.26 | 0.17–0.34 | C4 | 0.12 | 0.08–0.16 |
SF, survival fraction.